These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18708372)

  • 1. Cyclooxygenase-2 inhibitors in colorectal cancer prevention: counterpoint.
    Jankowski J; Hunt R
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):1858-61. PubMed ID: 18708372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coxibs: pharmacology, toxicity and efficacy in cancer clinical trials.
    Garcia Rodriguez LA; Cea-Soriano L; Tacconelli S; Patrignani P
    Recent Results Cancer Res; 2013; 191():67-93. PubMed ID: 22893200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of colorectal cancer - a new target needed?
    Spychalski M; Dziki L; Dziki A
    Colorectal Dis; 2007 Jun; 9(5):397-401. PubMed ID: 17504335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
    Gill S; Sinicrope FA
    Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 (COX-2) in carcinogenesis and selective COX-2 inhibitors for chemoprevention in gastrointestinal cancers.
    Fujimura T; Ohta T; Oyama K; Miyashita T; Miwa K
    J Gastrointest Cancer; 2007; 38(2-4):78-82. PubMed ID: 19031117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention?
    Manzano A; Pérez-Segura P
    ScientificWorldJournal; 2012; 2012():327341. PubMed ID: 22649288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
    Sandler RS
    Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The coxibs and traditional nonsteroidal anti-inflammatory drugs: a current perspective on cardiovascular risks.
    Cairns JA
    Can J Cardiol; 2007 Feb; 23(2):125-31. PubMed ID: 17311118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin and proton pump inhibitor combination therapy for prevention of cardiovascular disease and Barrett's esophagus.
    Peura DA; Wilcox CM
    Postgrad Med; 2014 Jan; 126(1):87-96. PubMed ID: 24393755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden.
    Brusselaers N; Lagergren J
    BMJ Open; 2018 Jul; 8(7):e021869. PubMed ID: 29982219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology and cellular/molecular mechanisms of action of aspirin and non-aspirin NSAIDs in colorectal cancer.
    Schrör K
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):473-84. PubMed ID: 22122764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemoprevention of colorectal cancer].
    Herszényi L; Juhász M; Prónai L; Tulassay Z
    Orv Hetil; 2004 Mar; 145(12):603-10. PubMed ID: 15119114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of colorectal cancer in general population and high-risk population: a systematic review and network meta-analysis.
    Ma Y; You W; Cao Y; He X; Wang J; Zhang Y; Li J; Li J
    Chin Med J (Engl); 2023 Apr; 136(7):788-798. PubMed ID: 37027286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase as a target for colorectal cancer chemoprevention.
    Moreira L; Castells A
    Curr Drug Targets; 2011 Dec; 12(13):1888-94. PubMed ID: 21158711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of colorectal neoplasia.
    Wakeman C; Keenan J; Eteuati J; Hollington P; Eglinton T; Frizelle F
    ANZ J Surg; 2017 Dec; 87(12):E228-E232. PubMed ID: 26686322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience.
    Fujimura T; Ohta T; Oyama K; Miyashita T; Miwa K
    World J Gastroenterol; 2006 Mar; 12(9):1336-45. PubMed ID: 16552798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice.
    Moore RA; Derry S; Phillips CJ; McQuay HJ
    BMC Musculoskelet Disord; 2006 Oct; 7():79. PubMed ID: 17054784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks of colorectal neoplasms and cardiovascular thromboembolic events after the combined use of selective COX-2 inhibitors and aspirin with 5-year follow-up: a meta-analysis.
    He P; Yang C; Ye G; Xie H; Zhong W
    Colorectal Dis; 2019 Apr; 21(4):417-426. PubMed ID: 30656820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase Inhibitors and Cancer: The Missing Pieces.
    Patrono C
    J Pharmacol Exp Ther; 2023 Aug; 386(2):181-189. PubMed ID: 37280092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.